<SEC-DOCUMENT>0000849146-14-000039.txt : 20140624
<SEC-HEADER>0000849146-14-000039.hdr.sgml : 20140624
<ACCEPTANCE-DATETIME>20140616091230
ACCESSION NUMBER:		0000849146-14-000039
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140616
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140616
DATE AS OF CHANGE:		20140616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		14921855

	BUSINESS ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9815 S. MONROE STREET
		STREET 2:		SUITE 100
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k12june2014.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2014 WebFilings LLC. All Rights Reserved -->
		<title>Form 8-K 12June2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s57AC1CDEEC1FD6AD0911826A82D9E99A"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________&#160;</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): June 16, 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td><td width="20%"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;text-align:center;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="32%"></td><td width="6%"></td><td width="28%"></td><td width="6%"></td><td width="28%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Colorado</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9785 S. Monroe Street, Suite 300, Sandy, UT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">84070</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801)&#160;432-9000</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="8%"></td><td width="92%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s131cd9ad6c614e1a8f73e363521a334b"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="16%"></td><td width="84%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;8.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Events</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 16, 2014, LifeVantage Corporation (the "Company") issued a press release announcing changes in its Japan operations.  A copy of the press release is attached as Exhibit 99.1 to this report. </font></div><a name="s3cc04f1f39b84e9e99877fbc0fe19e14"></a><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="16%"></td><td width="84%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="19%"></td><td width="6%"></td><td width="75%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release issued by the Company on June 16, 2014</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sedd74bb37dda4acd87871cc16ceec80e"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="448px"></td><td width="234px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: June 16, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By: </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Rob Cutler</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name: Rob Cutler</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: General Counsel</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleasejapanfinal.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 1 -->
		<!-- Copyright 2008-2014 WebFilings LLC. All Rights Reserved -->
		<title>PressReleaseJapanFINAL</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sC8D2427AEDBD6CF55A25A2DC229BA888"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:138%;padding-bottom:13px;text-align:center;"><img src="lifevantagelogojpega02.jpg" style="height:52px;width:334px;"></div><div style="line-height:138%;padding-bottom:13px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">LIFEVANTAGE ANNOUNCES CHANGES IN ITS JAPAN OPERATIONS</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">SALT LAKE CITY, UT, June 16, 2014 (GLOBE NEWSWIRE) &#8212; LifeVantage Corporation (Nasdaq: LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, today announced that it has appointed Jeffery Bean as its new Managing Director in Japan.  Mr. Bean brings 15 years of network marketing experience to LifeVantage, having worked in management positions for companies such as VISI, Stemtech International, LIV International, Synergy Worldwide and Neways, Inc. during his career.  Mr. Bean will be based in the Company&#8217;s Tokyo office.</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Douglas C. Robinson, the Company&#8217;s President and Chief Executive Officer said, &#8220;Our Japan market is very important to our overall business.  We are excited to have Jeff join our team in Japan and we believe he will add a great amount of stability and value to our Japan market.  Jeff brings a wealth of experience in the network marketing industry, particularly in Japan.&#8221;</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">In addition, the Company announced that it is working on a financial arrangement with two of its top distributor leaders in Japan who are no longer participating in the Company&#8217;s distributor activities.  The Company believes this arrangement will promote greater unity among its other distributor leaders in Japan.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">About LifeVantage Corporation</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">LifeVantage Corporation (LFVN), a leader in Nrf2 science and the maker of Protandim&#174;, the Nrf2 Synergizer&#174; patented dietary supplement, TrueScience</font><font style="font-family:inherit;font-size:11pt;">&#8482;</font><font style="font-family:Arial;font-size:12pt;">&#32;Anti-Aging skin care regimen with enhanced Nrf2 technologies, and Canine Health, is a science-based network marketing company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and is headquartered in Salt Lake City, Utah.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism and satisfaction with current prospects, as well as words such as &#8220;believe,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to,&#8221; &#8220;should&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements </font></div><br><div></div><hr style="page-break-after:always"><a name="sC8D2427AEDBD6CF55A25A2DC229BA888"></a><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">we make regarding how appointing a new managing director in Japan will affect our business in Japan and whether we will reach a mutual agreement with our distributor leaders and whether such an agreement will indeed promote the expected unity in that market. Such forward-looking statements are not guarantees of performance and the Company&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company&#8217;s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others the risk factors discussed in greater detail in the Company&#8217;s Annual Report on Form 10-K and its Quarterly Report on Form 10-Q under the caption &#8220;Risk Factors,&#8221; and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Investor Relations Contact:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Cindy England (801) 432-9036</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Director of Investor Relations</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">-or-</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">John Mills (310) 954-1105</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Partner, ICR, INC</font></div><div style="line-height:138%;padding-bottom:13px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lifevantagelogojpega02.jpg
<TEXT>
begin 644 lifevantagelogojpega02.jpg
M_]C_X``02D9)1@`!`0$`E@"6``#_X0!:17AI9@``34T`*@````@`!0,!``4`
M```!````2@,#``$````!`````%$0``$````!`0```%$1``0````!```7$5$2
M``0````!```7$0```````8:@``"QC__;`$,`"`8&!P8%"`<'!PD)"`H,%`T,
M"PL,&1(3#Q0=&A\>'1H<'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_;`$,!"0D)#`L,&`T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_``!$(`$\!]P,!(@`"$0$#$0'_
MQ``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#
M!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!
M`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<`
M`0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`
M$)`&2<`5E:Q<&;2KJ*UD83,AVE>/PS5G4'(1$'0\FL^MJ4=I'/6G=.!Q_A?7
M#I>JB&>1OLL_RL">%;L?Z&O0_M\/^U^5>>^)M#92]]:H6C/,J*/NGU'M5KPS
MX@2]C6QNI`+I!A&)_P!8/\:ZZ].-3]XCAPM2=']U+Y'<?;X?]K\J/M\/^U^5
M9E96MZW'HT"L8C+*_P!U,X&/4FN>-%2=D=<J[BKLZI+V%VQN(^HJQ7">'/%%
MOXA^T1+"T%S;XWQDY!!Z$&NRLG+VXSS@XJ*M+D-*5;G+-9-WXCTVRNGMIY76
M1/O`(3VS6M7FOB;_`)&*[^J_^@BM,)1C5FXR[&&/Q,\/34H=ST2TNHKVUCN(
M"3&XRI(Q4U97AO\`Y%ZS_P!T_P`S6K6%2*C-Q70ZJ4G.G&3ZI!1114&@445!
M>7"VEG-<,,B)"V/7`II-NR$VDKLBOM5LM-4&ZG5">B]6/X"H-.U^PU2=H;9G
M\Q5W89".*\ZDDN=2OB[;I;B9N!ZD]`/:NO\`#F@7NEZ@;BX\K:T17"MD@Y%=
M]7"TZ5/WG[QY-''5J]:T(^Z=31117GGKA1110`5FWWB#2-,NTM+[4;>WN'`*
MQRN%)!.!^M:5>=_%SP__`&CX>3584S<6!R^!R8CU_(X/YUI2C&<U&74RK3E"
MFY15['HE%<M\/_$'_"0^$[::1]UU;_N)_4LHX/XC!_.NIJ9Q<).+Z%PFIQ4E
MU"BBBI*&R2)#$\LKA(T4LS,<``=2:I:;K>EZSYG]FWT%UY6-_E-NVYZ9_(UQ
MWQ:\0?V7X:&FPOBXU`E#CJ(Q][\^!^)K5^'GA_\`X1_PG;QR)MNKG]_/QR"1
MP/P&!]<UM[)*ESOKL8>U;K>SCLEJ=71116)N%%%%`!1110`4444`%%%%`!7(
M>._&<O@^"RDBLDNOM+LI#2%=N`/8^M=?7E/QM_X\]&_ZZR_R6M\-!3JJ,MCG
MQ4Y0HN4=SU.&3S8(Y",;U#8],BGU!9_\>-O_`-<U_E4]8O<W6P4444AA1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%#4>L?XU1J]J/6/\`
M&LRYN8+.V>XN95BA099V/`KII_"CDJ_$R6N:UGP?;7K&>SE%G<DY']PG^A^E
M<EXD^(MY*6@T<&VASCSF&9&^G]W^=<K#I?B/4;B.]DM-2G0.&:616(QG.<FN
MRG1DM6['!5Q$;\J5ST0ZWXJ\/1[=3TEM1MD_Y>(&RP'N1U_$"KC>1XWT>.\L
MRUM-&QC:*<<J?0X_,'WJ/PSXC?4KJ;1+S<\HB+1R_P!Y>A!]QGK6MX?S']J@
M;[R.,_J/Z4G[J;M9HI6G97NF5?"WA4>'Y+JYEG6:YN,*=@(55'8>M=O8?\>Y
M_P!ZLRM.P_X]S_O5R5I.2NSMH1479%JO-?$W_(Q7?U7_`-!%>E5YKXF_Y&*[
M^J_^@BMLO_BOT.7-_P""O7]&=KX;_P"1>L_]T_S-:M97AO\`Y%ZS_P!T_P`S
M6K7)6_B2]6=^'_@P]%^05A>+G>/0F9'9&\Q>5.#UK=JIJ-[;:?:&>ZSY08#A
M<\GVHI-JHFE<,1%2I23=M-SC_!T\TFLNKS2./))PS$]Q6YXHU.WMM/ELI-_G
M7$9V87CKW-6M-UO3M1N3#:;O,"ECF/;Q61XQTZYN#'=QHIA@C/F$M@CGTKLN
MJF)3FN4\_E=+!R5*7-_6IS.CW<5CJUO<S`^7&23@9/0BN_TS7;/5I7BMO,W(
MNX[TQQ7G%K:RWMREO``9'.%!.*[+POHM]IEY/)=1JJO&%&'!YS6^-A3:YF_>
MZ')EE2LI*$5[K>NGD=16#J/BRPLG:*+=<RC@B,_*/Q_PK-\6ZXZN=-MG*\?O
MF!YY_A_QK%T?0+G5R74B*W4X,C#K[`=ZYZ.%@H>TK.R.O$XZHZGL<.KLU&\<
M7.[Y;*(+Z%SFKUEXTM96"7<#P9_C!W+_`(T]?!.G!,/-<LW]X,!^F*QM7\)S
MV$37%JYN(5&6!&&4>OO6B6#J/E6AC)YA27.]5\CNXI4FC62)U=&&593D&DG@
MCN;>2"9`\4JE'4]"",$5Y]X<UM],NUAD<FTE;#`G[A/\0_K7HM<>(H2HRL>E
MA,5'$POUZH\7\&SR>"?B1=^'KIR+6Z?RD+=">L;?B#C\:]HKRWXP:$YMK3Q#
M:@K-:L(IF7J%)RK?@W'XUW'A/7$\1>&K/401YCIMF`_AD'#?KS]"*TK_`+R$
M:J]'ZD8;]W.5%]-5Z&U1G`R:*X[XE>(/["\)S+$^VZO/W$6.H!'S-^`_4BN:
M$'.2BNIU5)J$7)]#A8,_$/XKM*?GTRR.1Z&-#Q_WTW/T->UUPGPJ\/\`]D>%
MEO)4Q<Z@1*<CD1_P#\LG\:I_$SQA<Z?Y7A_1V?\`M&[`\QH_O(IX"K_M-^@^
MM=55>UJJG#9:')1DJ-%U:F[U_P`D;'B/XCZ%X=E>W:1KN\7AH;?!VG_:;H/Y
MUR1^,&JW!+V?AHO".^]VX^H7%;G@_P"&6GZ1;QW>KQ)>ZDPW,L@W1Q'T`Z$^
MY_"N_5510J*%4<``8`J7*A#1+F\RE'$5-7+E\CS'3/C-82S"'5M-GLSG!>-O
M,`^HP"/UKH]%^(&EZ]XCDT>QBF<HK.MQQY;@8Y'.>_I6KK?AC2/$-NT6HV4<
MC$?+*!B1?HW6O*_`.FIHWQ8O=-CD:1+:.:-788)`(ZU:C1J0E**LTB)2KTIQ
MC)W39[6>!FN*TOXGZ#?PWLUP9+&.T*@FX(RY.>%`))/%=HWW3]*\!^'WA"U\
M4Z[>/?L3:69#-$IP9"Q.!GL.#FLZ%.$H2E/I8TQ%6I"<(T^MSL[KXQV;3&+2
M=&O+UAT).S/X`$U7_P"%LZM!^\N_"-S'#W;<XQ^:8KTJQTZRTRW6"QM(;>(#
M`6)`HJU2]I16T/Q'[*N]74_!''^'/B1H/B*9+99'M+Q^%AN,#<?16'!^G6NP
MKSSXB>!;"_T>YU>PMTM]0MD,S&(;1*HY(('?'(-:?PUU^?7_``G&]VY>YMG,
M$CGJ^`""??!'Y45*<'#VE/;J@IU9JI[*IOT?<9XH^(VG>%=6&G75G=2R&(2;
MHMN,'/J?:O,_'_CFQ\7P6,=G:W$)MG=F,NWG('3!/I7NEQIFGW<OFW-C;3R8
MQOEA5CCZD5Y9\8]/LK*TT@VEG;P%I)-QBB"YX7K@5MA94^>*2U,,9&K[.3<M
M.UB]!\9]&BMXXSIU\2B!3]SL/K7;^&/$=MXITC^T;6&6*/S&CVRXSD?0^]/M
M-#TAK.`G2K$DQJ23;IZ?2J7B;6['P7X;ENH;:%&+;8((U"!Y#[#MQD_2L9>S
MF^6G'7U.B'M*:YJDM/0MZ_XHTCPU;B74[H1LP^2)1ND?Z+_7I7`3_&62>8II
M6@2SJ#UDD.3_`,!4''YU4\'^";CQ?<-XE\42R31SMNBA)P91ZGT3T`_EU];M
M+*UL(%@L[:*WB48"1(%'Z5<E1I>ZUS/\#.+KUO>3Y5^)Y=!\998)@FJ^'Y85
M)ZI(0P_!@,_G6W<?%KP_&MH;9+BY-P<%54*T1R!A@3[]LUVMY8VFH6[07EM%
M<0L,%)4##]:\.^('A2P\,^(M.;3MZ0W;[O)8Y$9##H>N.>]725"K*W+9D5GB
M*,>;FNO0]YHH[5YU\2_&-QIB1:#I#-_:5V!O:/[T:DX`7_:8_E^5<E.FZDN5
M'95JQI0<I&QXD^(NA>')'MY)6NKQ>#!;X)4_[1Z#^?M7(_\`"X-3N"7L_#+/
M#V.]F_4+BMKP=\,;#28([S68DO-28;BLGS1Q'T`_B/N?PKT!45%"HH51P`!@
M"MW*A#1+F\SG4<14]YRY?(\QTSXS6,DXAU;3)[,YP7C;S`OU&`1^M=%H_P`0
M=+USQ*^C6,<TA"LRW`QY;@`'CG/?TK7UKPUI'B"W:'4;*.4D<2`8=?<-U%>4
M^!]+31?B[<Z;'(TD=LDJ*[#DC`ZU<8T:D9.*LTB)2KTIQC)W39[93))8X8FE
ME=4C099F.`!ZDT^O'/$NJZC\0O%?_"-:-*4TV!CYT@^ZVT_,[>H!X`[G].>E
M2=1]DMSIK5E36UV]D;^M?%_1;"9H-.@EU&0'&]#LCS[$\G\!6/\`\+>UA1YK
M^&&$/KN<<?7;BN[\.^"M%\-P*+6U22X`^>YE`:1C]>WT%=#6KJ4(Z*-_5F2I
MXB6LIV\DC@]!^*^A:O*MO=A].G8X'G$&,G_>'3\<5W8(8`@@@\@BN3\4?#[1
MO$=O(ZP):7V/DN(EQD_[0'WA^M<EX"\1:CX>\0-X.UXG`;9;.QSL;J%![JPZ
M?_7H=.%2+E2W704:M2G)0JZI[/\`S/6J***Y3L"BB@G`R>E`&5K=S#9V_P!H
MN'"11J2S'_/6O*;^XU/QGJHM[9"L"'*H3\L8_O,?7_(K;\1ZC<>+-;33;`YM
M(6.&['U<^WI_]>NAL[2R\/Z<(D#+&.9)-A)8^IQ7H4X^SBNYYM62J2=G[I2T
M/PAIFBA9?*6YO.\\JYP?]D=OYULWA_T*X)/2)OY4EM>6UXI:VN(Y0.NULD?A
M1>_\>%S_`-<F_E4W;EJ.T5'W3S?P;_R/1_Z])/YK7=D?8]>5^D=TNT_[P_S^
MM<)X-_Y'H_\`7K)_-:]&OK47=L8P=L@.Y&]&'2MJKM/7L84%>GIW+-:=A_Q[
MG_>K)A,C0H9E"R$?,`<\UK6'_'N?]ZN.KL=U'XBU7FOB;_D8KOZK_P"@BO2J
M\U\3?\C%=_5?_016^7_Q7Z')F_\`!7K^C.U\-_\`(O6?^Z?YFM6LKPW_`,B]
M9_[I_F:U:Y*W\27JSOP_\&'HOR"L#QA_R`&_ZZ)_.M^L#QA_R`&_ZZ)_.JP_
M\6/J1C/]WGZ,P/!?_(:D_P"N)_F*ZOQ#_P`B_>_]<S7*>"_^0U)_UQ/\Q75^
M(?\`D7[W_KF:ZL5_O*^1PX+_`'*7S_(X?PW_`,C#9_[Q_D:]*8A5+'H!DUYK
MX;_Y&&S_`-X_R->E,NY&4]QBEF'\1>@\H_@R]?T1Y+<3&YNY)I"<R.68_4UV
M=MXLT>TMH[>**Y6.-=H'EC_&N+EB,-P\4@(*.5;UX-=;#X+M9X4ECU"1D=0R
MD(.0:[,2J/*O:/0\[!/$<TG12;ZW+G_"::9_SSN?^^!_C1_PFFE_\\[G_OV/
M\:K?\(-!_P`_TO\`WP*/^$&@_P"?Z7_O@5R<N#[L]#FS'LOP_P`SE+][:2^F
M>T5E@=MRJPP1GM7H^A7#76B6DK'+&/:3[CC^E8?_``@T'_/]+_WP*Z'3;%=-
MT^*T5RXCS\Q&"<DG^M&+K4JE-1@[M!@,-7I592J*R8NI6$&JZ9<V%RN8;B,Q
MM^(Z_45Y/\,K^?P]XKU#PK?MM\QV\O/3S%]/]Y>?P%>Q5Y%\5]*FTO6=/\56
M&4D#JDC#M(O*$_4`C\!6.&:E>D^OYG7BDXVK+[/Y'KM>*^(';Q]\4H-)B8M8
M6;&-B#QM4YD;\3\OY5W6N>,X+?X>?V]:L!)=1!+=<])6XQ_P$Y_[YK%^$&@&
MTT>?6YU/GWK;8RW7RP>OXMG\A3HITH2J/?9>I-=JM.-);;OT/2$18XU1%"HH
M`4#H!7CW@J,>(_BMJVK7'SBU:1XP><'=L3\ES7L=>/?#I_[(^).MZ5<';)*9
M%3/<J^1_XZ2:5#X)M;V*Q/\`$II[7_X8]AHHHKE.P*\B\-?\EQUC_MM_[+7K
MM>1>&O\`DN.L?]MO_9:Z</\`#/T.3$_%3]3UQONGZ5Y+\&?^/_7OK'_-Z]:;
M[I^E>2_!G_C_`->^L?\`-Z*7\&I\OS"M_'I_/\CUNBBBN8ZS.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KN]?_Y%S4_^O27_`-`-<)\%?^1;U#_K[_\`
M9%KIA_N\O5')4_WF'HSTRO*?C;_QYZ-_UUE_DM>K5Y3\;?\`CST;_KK+_):,
M)_&B/&_P)?UU/3[/_CQM_P#KFO\`*O)_B>7UGQSH>@!B(CLR/>1\$_D*]8L_
M^/&W_P"N:_RKR?XBL=(^)>A:O)_J,1DG_<<[OT(IX7^+YZDXS^#Y75SUR&&.
MW@C@A0)%&H1%'0`#`%/I`0RAE(((R".]+7*=@5Y'\8?^0UX?^K?^A+7KE>1_
M&'_D->'_`*M_Z$M=.$_C+Y_D<F._@/Y?F>N=J\=\(1CQ'\7-5U2X^=;1I'C#
M<X(.Q/R'\J]B[5X]X`<:/\4=;TN<[6F,JIGN0^X?FN33P_P3MO86)_B4T]K_
M`/#'L-%%%<IV!7D6@_\`)=M4_P"VO_H*UZ[7D6@_\EVU3_MK_P"@K73A_AGZ
M')B?BI^IZ'XMU!]+\):I>1G$D=NVP^C'@'\S7GOPJU'0-$T2ZN+_`%2SM[VY
MFP5EE`8(HXZ^Y)KO?&]H]]X*U>",$N;=F`'?;\W]*\S^'G@KP]XJT.:>]^T?
M;()BCB.7:-I`*G&/K^5:4>3V$N;N9UW/ZQ'E73J>G?\`":^&/^@]I_\`W_6C
M_A-?#'_0>T__`+_K7/\`_"H/"W]V]_[_`/\`]:C_`(5!X6_NWO\`W_\`_K5G
MRX?NS7FQ/9'0?\)KX8_Z#VG_`/?]:\R^*FH:/?7.F:MH^I6T]["Q1_(D#,`/
MF4\>AS^==;_PJ#PM_=O?^_\`_P#6H_X5!X6_NWO_`($?_6K2E*A3ES)LRK0Q
M%6#@TCL]-NOMVEVEWT\^%)/^^@#_`%HI]G:QV-E!:0Y\J"-8TW')P!@45QNU
M]#N5[:D]<IXVUE[2R73K4DW5UP=O4)T_,]/SKIYYX[:WDGE;;'&I9CZ`5Q?A
MJVDUW7[G7KM?W<;XA4]`W;\A^IK:C%:U);+\SGQ$V[4H[R_+J7M(\/KH>EQ[
M@#=2\S-Z'LH]A5VMMT61"K#(-5#IRYXD('N*:JWUD#H\ND=CC-<\.M+F_P!)
M8V]^GS`1G:)/\#_.J&B>,$U:VNM-OP(=22)\#&!+@'.!V8=Q7H/]G#_GJ?\`
MOFO+?B3X5:QU6QURSSLFG6.XVC&U\\-^/0__`%ZZ*52-1\C?H<E>G.G%SBO4
MI^#?^1Z/_7K)_-:]/KS7P/%YWC\INQ_HDAZ>ZUZS_9P_YZG_`+YHQ$TIV8\+
M"3A=%"M2P!%MD]SD4Q-/0'+.6'IC%6P`H``P!TKDG--61VTZ;3NQ:\U\3?\`
M(Q7?U7_T$5Z57+:KX4FU'4YKM;M$60C"E"<8`%;X*I&G4;D[:'+F5&I6I*--
M7=RII/BNTT_2X+62WF9XQ@E<8//UJ[_PF]E_SZW'_CO^-4?^$'N/^?Z+_OV?
M\:/^$'N/^?Z+_OV?\:Z)+!R;;?YG'!YC&*BHZ+T-:Q\5VE_>Q6L=O,K2'`+8
MP./K1XP_Y`#?]=$_G532_"<VGZE#=-=QN(R25"$9XQ6SK>FOJNFFUCD6-BX;
M<PR.*YVZ,*T73>AUQ6(J8:<:J]YWL<EX+_Y#4G_7$_S%=;KPSH-[G_GD:S="
M\-SZ1?M<27$<BF,IA5([C_"MG4;5KW3I[96"M*A4,1P*>(JPE74HO306$HU(
M85PDM=3S[PW_`,C#9_[Q_D:]+KE-+\)W&GZG!=/=1.L9)*A3D\8KJZ6-J1J3
M3B[Z#RVC4I4FJBL[G$^+=&>.=M2@3,3_`.N`_A/K]#5'1/$DVE+Y$J&:USD*
M#\R?3_"O0R`RE6`((P0>]<SJ/@VVN':2RE^SL?X",I_]:M*.)IRA[.ML8XC!
M585?;89Z]BTOB[2&3<9I%/\`=,9S6/JOC%YD,6G(T0[RN.?P%5F\&:F&P)+8
MCUWG_"K]EX)`<-?7.Y1_!$,9_$U:CA*;YKW,Y5,PJKDY;>>W]?(V/#^L_P!K
MV9+QE9HL!R!\I]Q_A6O45O;0VD"PV\:QQKT514M>?4<7)N*LCUZ49Q@E-W85
ME^(M'BU_0+S3)<#SHR$8_P`+CE3^!Q6I14IM.Z+DE)69\RZ?::KJ^H67A-W=
M5CNW'E$?ZICPY_`*3^?K7TI:6L-C9PVEN@2&%!&BCL`,"L2S\)6EGXROO$28
M\RYB5`F/NM_&WX@+^OK70UTXFNJMK;?J<F$P[HIN6_Z=`KRGXF>'[W3=6@\8
MZ.")82IN-HSM*]'QZ8X->K4C*KJ590RL,$$9!%8TJCIRYD;UJ2JPY6<WX2\:
M:=XJLE,4BPWRK^^M6/S`]ROJOO\`G72UYMX@^$MK=71O=!NSIUQG=Y7/E@^J
MD<K^&:RET+XJV8\F'5/.C'`8W"M^KC-;.E2GK"5O)F"K5H:5(7\T>L7=Y;6%
MJ]S=SQP01C+22-@"O'_!5];ZG\8=2OK5B]O.LSQL1C(R.<59C^&?BC7ITE\3
M:Z?+!SL60RL/H.%'ZUO>%_AR_AGQ9)J<-XCV7EM''$02X!QC)Z=JN*I4X27-
M=M&<G6JSB^6R3^9WS?=/TKR7X,_\?^O?6/\`F]>M'D$5QG@7P5<^$KC49;B\
MAN!=[=HC4C;@MUS]:QISBJ4XO=V-ZL).M"2V5_R.THHHK`Z3.U__`)%S4_\`
MKTE_]`-<)\%?^1;U#_K[_P#9%KT/4K5KW2[NT5@K3PO&&/0%@1G]:YWP'X3N
M/".EW-I<74=PTLWF!HU(`&`,<_2MXSBJ,H]=#FG"3KQDMDF=77E/QM_X\]&_
MZZR_R6O5JX[Q]X-N?&$%C';W<5N;9W9C(I.[('I]*,-)0JJ4MAXJ$IT7&.YU
M5G_QXV__`%S7^5<W\0/"Q\4^'FB@`^W6Q\VW)_B..5_$?J!73P1F*WCC)R44
M+GZ"I*SC-PES1-9P4X<LNIYA\/?'L0MT\/:\YMKVV_=123?*'`X"-GHPZ<]?
MK7I_49%<EXK^'ND^*2;A@;2_QC[1$!\W^\/XOY^]<:G@WXB:$/)TG6A-;C[J
MB?`'_`7&!^%=$HTJKYHOE?9G+&5:BN64>9=T>OUXI\4M:T_5/$FE6]C<I.]J
MQ68H<JI++QGN>*N/X.^(NNCR=6UI8;<_>4S\'_@*#!_&IYO@R(OL1L=3'F1M
MNG>9#\YR,;0.@Z^M:48TJ4N:4KOR,Z\JU:'+&%EYGK':O*_B;X>O++4K?Q?I
M`836Y4W&P<KM^Z_N,<'VQ[UZI2,H92K`%2,$$=:Y*51TY<R.RM256'*SF?"/
MC;3O%5DFQTAOU7]]:L>0?5?5?\FNGKS?Q#\);.\NC>Z%='3;G.[R\'R\^HQR
MOX5E#0OBI9#R8-5$T8X#&X5OU<9K9TJ4]82MY,P5:M#2I"_FCU>ZNK>RMGN;
MJ:.&&,9:21@`!]:\?\(7]OJGQGOKZT<O;S+,T;$8R,`9JPGPU\4Z_.DGB;73
MY2G.P2&5A]!PHJIX,TV#1_C%=:=;;_(MTE1-YR<;1U-:TX0A"=I7=C&K4J3J
M0;C97^9[00&!!`((P0:\6N%N_A7XW:YCB>71+XD87^[G.W_>7MZCZU[5534M
M,LM7L9+*_MTGMY!\R,/U'H?>N:C5Y&U)73W.NO1=1)Q=FMANE:O8:U8I>:=<
MI/"XZJ>5/H1U!]C5VO)[WX4ZII=XUWX5UMX">D<CLC#VW+U_$5%_8_Q8<>2=
M2"ITW^?&/U`S6GL*<M8S5O,S6(J1TG!W\CTC7O$>F^&[!KK4;A4X^2('+R'T
M4=ZJ^$/%,7BS1S?1VTMNR.8W1^1G_9;N*XO2OA+/<WHOO%&JO>29R8HW8[O8
MNW./8`?6O3;6UM[&UCMK6%(8(EVI&@P%%145*,;1=WW+I2K3ES25EVZE:YUO
M3+.\%I<WT,4Y&[:[8P.V3T&??K17.:QX1O+[5;B:"6U\F=M^Z=2Q0X4'Y?XO
MNC!R,`GKQ10H4K:R$ZE9-VB3>-KY_(@TJWR9KE@6`],\#\3_`"KH-*L$TS3(
M+1,?NU^8^K=S^=<MHR_VWXMN=2?F*W_U8/Y+^@)^M=K55_<BJ7S?J9X7][.5
M=]=%Z(****YCM"J][96^H6KVUU$)(7QE3['(_6K%%--IW0FDU9F/IOA;1])O
MVO;*S$=RR;#(79CM]!D\5L444.3D[MA&*BK15@HHHI#"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO)/$WQ.UW0O$E_IL=G8O%%
M)B)I%;=MQWPU:TJ4JKM$RK5H45>1ZI>7<%A9S7=U*L4$*%W=CP`*\H^&BRZ]
MXZUKQ(Z%8?F"Y_O.V0/P4?J*IIIOC?XC^6;^XBM=+W`G:P"?@@)+'_>KU?0=
M"LO#FDQ:=8H1&G+,WWG8]6/N:V:C1@XWO)_@<\7+$5(RM:*_%FG1117(=H44
-44`%%%%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
